Deborah J Andrews
Chief Financial Officer & EVP; Director; Interim Co-CEO and CFO · 6 filings · Latest: Aug 14, 2026
Lineage Cell Therapeutics, Inc.
STAAR SURGICAL CO
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
STAA | Deborah J Andrews | Chief Financial Officer & EVP | Aug 14, 2026 | Option Exercise | $0.00 | 5,233 | — | 41,452 | |
STAA | Deborah J Andrews | Chief Financial Officer & EVP | Jul 31, 2026 | Option Exercise | — | 20,787 | — | 46,915 | |
STAA | Deborah J Andrews | Chief Financial Officer & EVP | Jun 25, 2026 | Option Exercise | — | 13,955 | — | 32,608 |